EGFR and colorectal neoplasm: For instance, overexpression of the epidermal growthfactor receptor (EGFR) is observed in three-fourths of primary colorectal tumors(Hemming et al., 1992; Mayer et al., 1993) and provides support fortargeting these cells using panitumumab, a monoclonal antibody against EGFR.